Heartflow (HTFL) Amortization of Deferred Charges (2024 - 2025)
Heartflow's quarterly Amortization of Deferred Charges came in at $1.6 million in Q3 2025, up 1044.29% year-on-year from $140000.0 in Q3 2024, and up 1077.94% quarter-over-quarter from $136000.0 in Q4 2024.
Heartflow has reported Amortization of Deferred Charges for 2 years, with the latest figure at $1.6 million in Q3 2025.
- For the quarter ending Q3 2025, Amortization of Deferred Charges rose 1044.29% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $1.9 million (changed N/A YoY), and the FY2025 full-year result was $5.4 million, up 233.56% from the prior year.
- Amortization of Deferred Charges for Q3 2025 stood at $1.6 million, up from $136000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $1.6 million in Q3 2025, with the low at $136000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Dec 31, 2024 | 136,000.00 |
| Dec 31, 2024 | 136,000.00 |
| Sep 30, 2024 | 140,000.00 |
| Sep 30, 2024 | 140,000.00 |